BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/20/2026 9:06:33 AM | Browse: 1 | Download: 0
 |
Received |
|
2025-08-06 15:05 |
|
Peer-Review Started |
|
2025-08-06 15:05 |
|
First Decision by Editorial Office Director |
|
2025-09-01 08:36 |
|
Return for Revision |
|
2025-09-01 08:36 |
|
Revised |
|
2025-09-03 18:02 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-11-17 02:44 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-11-17 09:30 |
|
Articles in Press |
|
2025-11-17 09:30 |
|
Edit the Manuscript by Language Editor |
|
2025-11-21 00:48 |
|
Typeset the Manuscript |
|
2025-12-09 11:02 |
|
Publish the Manuscript Online |
|
2026-01-20 09:06 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Case Control Study |
| Article Title |
Prognostic significance of PD-L1/PD-1 co-expression and CXCR3-driven inflammatory signatures in Egyptian patients with lymphoproliferative neoplasms
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Dalia E Sherief, Nahla Nosair, Aya Mohammed Abdelhameed, Emad Sadaka, Amira A A Othman and Rasha Elgamal |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Amira A A Othman, Chief Physician, MD, PhD, Professor, Department of Internal Medicine, Faculty of Medicine, Suez University, Suez 43511, As Suways, Egypt. amira.othman@med.suezuni.edu.eg |
| Key Words |
Lymphoproliferative neoplasms; Programmed death ligand-1; Programmed death 1; C-X-C motif chemokine receptor 3; Systemic immune-inflammation index; Systemic inflammation response index; Inflammatory biomarkers |
| Core Tip |
This case-control study explores the prognostic value of programmed death ligand-1/programmed death 1 co-expression and C-X-C motif chemokine receptor (CXCR) 3-driven immune signatures in Egyptian patients with lymphoproliferative neoplasms. By integrating flow cytometric analysis with systemic inflammation indices - systemic immune-inflammation index and systemic inflammation response index - the study identifies novel biomarker panels predictive of disease stage, recurrence, and survival. Findings support the use of programmed death ligand-1/CXCR3 and programmed death 1/CXCR3 as clinically relevant tools for risk stratification in resource-limited settings, paving the way for personalized management of lymphoproliferative neoplasms. |
| Publish Date |
2026-01-20 09:06 |
| Citation |
Sherief DE, Nosair N, Abdelhameed AM, Sadaka E, Othman AAA, Elgamal R. Prognostic significance of PD-L1/PD-1 co-expression and CXCR3-driven inflammatory signatures in Egyptian patients with lymphoproliferative neoplasms. World J Clin Oncol 2026; 17(1): 112801 |
| URL |
https://www.wjgnet.com/2218-4333/full/v17/i1/112801.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v17.i1.112801 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
